⚖

Compare Funds

See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.

MF
—Motilal Oswal Focused Fund - Growth - Direct PlanDirect · Growth
₹61.81 as on 30 Oct 2026
VS
HD
HDFC MFHDFC Pharma and Healthcare Fund - Growth - Direct PlanDirect · Growth
₹21.95 as on 30 Oct 2026
▤Key Metrics Comparison
MetricMFMotilal Oswal Focused Fund - Growth - Direct PlanHDHDFC Pharma and Healthcare Fund - Growth - Direct Plan
Snapshot
AMC—HDFC MF
CategoryEquity - Focused FundEquity - Sectoral Fund - Pharma & Health Care
NAV₹61.81 (30 Oct 2026)₹21.95 (30 Oct 2026)
Rating★★★★★★★★★★
BenchmarkNIFTY 500 - TRIBSE Health Care - TRI
Fund ManagerAnkit AgarwalNikhil Mathur
Inception13 May 201304 Oct 2023
Returns
1Y20.86%22.64%
3Y14.97%30.41%
5Y10.53%—
Since Inception14.60%29.15%
Risk
18.1914.07
1.060.59
0.511.59
5.1921.67
0.933.48
-15.56%-9.23%
Costs
Expense Ratio1.66%1.03%
Exit Load1% on or before 365D, Nil after 365D1% on or before 30D, Nil after 30D
Min SIP₹500₹100
Min Lumpsum₹500₹100
Lock-inNoneNone

Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.

◐Portfolio Overlap
Motilal Oswal…97%
HDFC MF97%
3.1%

Only 3.1% of holdings by weight are common between Motilal Oswal Focused Fund - Growth - Direct Plan and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.

Common holdingMotilal Oswal Focused Fund - Growth - Direct PlanHDFC MF
Acutaas Chemicals Ltd.3.10%3.18%

Category context: Equity vs Equity. Open the full Screener →